Table: Zeria Pharm -2016/17 group results

Zeria Pharmaceutical

12/05/2017 08:00

May 12 (Reuters)-  
          Zeria Pharmaceutical Co Ltd  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended       Year to       NEXT    
              Mar 31, 2017    Mar 31, 2016   Mar 31, 2018     YEAR      
                 LATEST         YEAR-AGO        COMPANY      COMPANY    
                 RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales           64.85           62.48          68.00        33.00     
               (+3.8 pct)      (+2.4 pct)     (+4.9 pct)    (+2.1 pct)  
  Operating        4.54            4.57           5.00         2.30     
               (-0.5 pct)      (+70.4 pct)    (+10.1 pct)  (-27.0 pct)  
  Recurring        4.44            4.45           5.00         2.30     
               (-0.3 pct)      (+60.7 pct)    (+12.7 pct)  (-25.4 pct)  
  Net 
  Net              3.54            3.51           3.80         1.60     
               (+0.9 pct)      (+37.4 pct)    (+7.2 pct)   (-20.3 pct)  
  EPS           66.73 yen       66.15 yen      71.54 yen    30.12 yen   
  Ann Div       32.00 yen       31.00 yen      34.00 yen                
  -Q2 Div       16.00 yen       15.00 yen      17.00 yen                
  -Q4 Div       16.00 yen       16.00 yen      17.00 yen                
   
  NOTE - Zeria Pharmaceutical Co Ltd. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T 
  ((Tokyo Headline News Desk +813 6441 1812))